Search results
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga via Yahoo Finance· 3 days agoProteologix’s portfolio includes: PX128, a bispecific antibody targeting IL-13 plus TSLP, which is...
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Morningstar· 3 days agoProteologix’s portfolio includes PX128, a bispecific antibody targeting IL-13 plus TSLP, which is ready to enter phase 1 development for moderate to severe atopic dermatitis ...
Johnson & Johnson to acquire Proteologix for $850 million
Reuters via Yahoo Finance· 3 days agoProteologix's antibody PX128 is ready to enter early-stage development for moderate to severe atopic...
Jasper Therapeutics targets asthma in new Phase 1b/2a study By Investing.com
Investing.com· 6 days agoJasper Therapeutics, Inc. (NASDAQ:JSPR), a biotech company specializing in antibody therapies,...
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Benzinga· 3 days agoThursday, Johnson & Johnson JNJ agreed to acquire Proteologix Inc., a privately held biotechnology...
Boy, 6, awarded for bravery after saving mum
BBC via Yahoo News· 5 days agoDimitri Clark dialled 999 and asked for help when his mum could not speak [EEAST] A six-year-old boy who helped save his mum after she had a severe ...
Blackstone-backed biotech launches with up to $300M for immune drug
BioPharma Dive via Yahoo Finance· 4 days agoUpstream Bio launched in 2022, raised new funds in 2023 and this year announced the start of a Phase...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 7 days agoRegeneron Pharmaceuticals, Inc. REGN and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application ...
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
Zacks via Yahoo Finance· 2 days agoThe company’s pipeline includes a phase I ready candidate, PX128, a bispecific antibody targeting...
J&J to Lead in Atopic Dermatitis Treatment with Recent Acquisition
New Jersey Business Magazine· 4 days agoJohnson & Johnson has entered into a definitive agreement to acquire Proteologix, Inc. for $850...
